Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Statins for the primary prevention of cardiovascular disease

(2014) S. Ebrahim et al.   BMJ-British Medical Journal

Gender and racial disparities in adherence to statin therapy: A meta-analysis

(2013) Jennifer Lewey et al.   AMERICAN HEART JOURNAL

Hypertension Control in Community Health Centers Across China: Analysis of Antihypertensive Drug Treatment Patterns

(2013) Zengwu Wang et al.   AMERICAN JOURNAL OF HYPERTENSION

Evaluation of the impact of the recent controversy over statins in France: The EVANS study

(2013) Anis Saib et al.   Archives of Cardiovascular Diseases

Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)

(2013) Erika Turkstra et al.   BMC Cardiovascular Disorders

A price and use comparison of generic versus originator cardiovascular medicines: a hospital study in Chongqing, China

(2013) Wenjie Zeng   BMC HEALTH SERVICES RESEARCH

Statins for primary prevention of cardiovascular disease

(2013) C. Michael Minder et al.   CURRENT OPINION IN CARDIOLOGY

The Large Social Value Resulting From Use Of Statins Warrants Steps To Improve Adherence And Broaden Treatment

(2013) David C. Grabowski et al.   HEALTH AFFAIRS

Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease

(2013) Kevin F. Erickson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010

(2013) Gonghuan Yang et al.   LANCET

China’s biggest, most neglected health challenge: Non-communicable diseases

(2013) Shenglan Tang et al.   Infectious Diseases of Poverty

Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

(2012) Linda J Cobiac et al.   BMC PUBLIC HEALTH

Randomized Polypill Crossover Trial in People Aged 50 and Over

(2012) David S. Wald et al.   PLoS One

The economic burden of hypertension in rural south-west China

(2012) Cai Le et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Dietary patterns and hypertension among Chinese adults: a nationally representative cross-sectional study

(2011) Dong Wang et al.   BMC PUBLIC HEALTH

Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk

(2011) J. Conly et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era

(2011) Lawrence D. Lazar et al.   CIRCULATION

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET

Future Cardiovascular Disease in China

(2010) Andrew Moran et al.  

Variations and Determinants of Hospital Costs for Acute Stroke in China

(2010) Jade W. Wei et al.   PLoS One

Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review

(2009) Lis Neubeck et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Cohort Profile: The China Health and Nutrition Survey--monitoring and understanding socio-economic and health change in China, 1989-2011

(2009) B. M. Popkin et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY